MPLN's Next Generation Sequencing (NGS) Gene Panels target hotspot mutations and can be ordered individually, or in the case of oncology are orderable in conjunction with other appropriate molecular and cellular tests targeting tumor site. The resulting analyses and interpretation enables selection of appropriate therapies based on guidelines and selection of applicable clinical trials.
B-cell IGH Gene Rearrangement by Next Generation Sequencing
BRAF Mutation Analysis by Next Generation Sequencing
Colon Cancer Panel by Next Generation Sequencing
EGFR Mutation Analysis by Next Generation Sequencing
IgVH Somatic Hypermutation by Next Generation Sequencing
KRAS Mutation Analysis by Next Generation Sequencing
MYD88 p.L265P Mutation Analysis by Next Generation Sequencing
Myeloid Extended Mutation Analysis Panel by Next Generation Sequencing